The use of oral anticoagulation at the time of acute COVID-19 infection and subsequent development of long-COVID/post-acute sequelae of SARS-CoV-2 infection
Frost, Freddy; Rivera-Caravaca, José Miguel; Lip, Gregory Y. H.
Long COVID (LC) or post-acute sequelae of SARS-CoV-2 infection (PASC) is...
Impact of treatment of COVID-19 with sotrovimab on post-acute sequelae of COVID-19 PASC: an analysis of National COVID Cohort Collaborative N3C data
Drysdale, Myriam; Chang, Rose; Guo, Tracy; Duh, Mei Sheng; Han, Jennifer; Birch, Helen; Sharpe, Catherine; Liu, Daisy; Kalia, Sarah; Van Dyke...
COVID 5 years later: Learning from a pandemic many are forgetting
Five years after SARS-CoV-2 surfaced, scientists reflect and look ahead to the next threat
https://www.science.org/content/article/covid-5-years-later-learning-pandemic-many-are-forgetting
(I added some line breaks and bolding...
https://onlinelibrary.wiley.com/doi/10.1111/joim.20033
Abstract
Background
Bacillus Calmette–Guérin (BCG) injected during the COVID-19 convalescence period was safe and enhanced recovery from anosmia and dysgeusia in the acute phase.
Objectives
To report the long-term results of the BATTLE...
[I think this belongs here - please move if necessary]
A Fight About Viruses in the Air Is Finally Over. Now It’s Time for Healthy Venting
https://www.scientificamerican.com/article/a-fight-about-viruses-in-the-air-is-finally-over-now-its-time-for-healthy/
Protecting yourself from COVID-19 these days is hard. And it comes at a cost.
https://www.marketplace.org/2024/03/20/protecting-yourself-from-covid-19-these-days-is-hard-and-it-comes-at-a-cost/
Rampant COVID Poses New Challenges in the Fifth Year of the Pandemic
“We’re still in a pandemic,” says a lead COVID official with the World Health Organization
https://www.scientificamerican.com/article/rampant-covid-poses-new-challenges-in-the-fifth-year-of-the-pandemic/
(some extra line...
Effectiveness of Nirmatrelvir–Ritonavir Against the Development of Post–COVID-19 Conditions Among U.S. Veterans
Background:
COVID-19 has been linked to the development of many post–COVID-19 conditions (PCCs) after acute infection. Limited information is available on the effectiveness of oral...
Physical interventions to interrupt or reduce the spread of respiratory viruses
Background
Viral epidemics or pandemics of acute respiratory infections (ARIs) pose a global threat. Examples are influenza (H1N1) caused by the H1N1pdm09 virus in 2009, severe acute respiratory syndrome (SARS) in...
Nirmatrelvir/ritonavir and risk of long COVID symptoms: A retrospective cohort study
We conducted a retrospective cohort study to assess whether treatment with nirmatrelvir/ritonavir was associated with a reduced risk of long COVID. We enrolled 500 adults with confirmed SARS-CoV-2 who were...
New op-ed in The Philadelphia Inquirer by Jennie Spotila:
Let’s approach COVID like the weather. Depending on conditions, we grab an umbrella (or mask)
Tweet from the author:
The feasibility and acceptability of an early intervention in primary care to prevent chronic fatigue syndrome (CFS) in adults: randomised controlled trial
https://pilotfeasibilitystudies.biomedcentral.com/articles/10.1186/s40814-020-00595-0
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.